Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
$MJNA Emmy® Award-Winning Daytime Talk Show CBS' The Doctors Featured Medical Marijuana, Inc. Flagship Product Real Scientific Hemp Oil™ https://www.nasdaq.com/press-release/emmy-awardwinning-daytime-talk-show-cbs-the-doctors-features-medical-marijuana-inc-flagship-produc-20180326-00579
$MJNA Emmy® Award-Winning Daytime Talk Show CBS' The Doctors Featured Medical Marijuana, Inc. Flagship Product Real Scientific Hemp Oil™ https://www.nasdaq.com/press-release/emmy-awardwinning-daytime-talk-show-cbs-the-doctors-features-medical-marijuana-inc-flagship-produc-20180326-00579
$KNDI breaking out
$MJNA up on news
KNDI Breaking out
$MJNA up on news
$GEVO EPA Approves Registration of Isobutanol in 16% Blends in Gasoline http://ir.gevo.com/phoenix.zhtml?c=238618&p=irol-newsArticle&ID=2354941
$GEVO EPA Approves Registration of Isobutanol in 16% Blends in Gasoline http://ir.gevo.com/phoenix.zhtml?c=238618&p=irol-newsArticle&ID=2354941
$GEVO new website? Web Address:
http://www.gevo.com
$GEVO new website? Web Address:
http://www.gevo.com
$KNDI Kandi Pure EV Model K22 http://www.nasdaq.com/press-release/kandi-pure-ev-model-k22-receives-two-approvals-from-chinese-government-agencies-20171206-00453 … #electricvehicles #gasprices #oil
$KNDI Kandi Pure EV Model K22 http://www.nasdaq.com/press-release/kandi-pure-ev-model-k22-receives-two-approvals-from-chinese-government-agencies-20171206-00453 … #electricvehicles #gasprices #oil
$INSY INSYS Therapeutics and University of California (UC) San Diego Center for Medicinal Cannabis Research to Collaborate on Clinical Trial https://globenewswire.com/news-release/2018/04/26/1488081/0/en/INSYS-Therapeutics-and-University-of-California-UC-San-Diego-Center-for-Medicinal-Cannabis-Research-to-Collaborate-on-Clinical-Trial.html
$INSY INSYS Therapeutics and University of California (UC) San Diego Center for Medicinal Cannabis Research to Collaborate on Clinical Trial https://globenewswire.com/news-release/2018/04/26/1488081/0/en/INSYS-Therapeutics-and-University-of-California-UC-San-Diego-Center-for-Medicinal-Cannabis-Research-to-Collaborate-on-Clinical-Trial.html
$MJNA Medical Marijuana, Inc. (OTC:MJNA), the first publicly traded cannabis company in the United States, garnered news coverage with a feature story in top national newspaper The Washington Post.
A March 28, 2018 article on The Washington Post’s website entitled “CBD is cannabis that won’t get you high. So why are so many people using it?” takes a deep dive into the story behind the rise in popularity of cannabidiol (CBD) in the United States. The article quotes Medical Marijuana, Inc. CEO Dr. Stuart Titus and recognizes Medical Marijuana, Inc. as a producer of several CBD oils and products that entered the market in 2012.
Medical Marijuana, Inc. was the first company to ever create a global CBD pipeline with its flagship product, Real Scientific Hemp Oil™ (RSHO™), and now has several distribution subsidiaries such as HempMeds®, Kannaway® and Phyto Animal Health. The company also operates in many other countries around the world and was the first to receive historic federal government import approvals for its CBD products in the nations of Brazil, Mexico and Paraguay. The company has since set up distribution subsidiaries in those countries as well.
“We are thrilled to be acknowledged by such a prestigious national publication highlighting Medical Marijuana, Inc. as a leader in the CBD industry,” said Medical Marijuana, Inc. CEO Dr. Titus. “This kind of media coverage helps us communicate the health and wellness benefits of CBD, while shedding light on the company’s accomplishments.”
About Medical Marijuana, Inc.
We are a company of firsts®. Our mission is to be the premier cannabis and hemp industry innovators, leveraging our team of professionals to source, evaluate and purchase value-added companies and products, while allowing them to keep their integrity and entrepreneurial spirit. We strive to create awareness within our industry, develop environmentally-friendly, economically sustainable businesses, while increasing shareholder value. For details on Medical Marijuana, Inc.’s portfolio and investment companies, visit www.medicalmarijuanainc.com.
https://www.medicalmarijuanainc.com/top-u-s-newspaper-washington-post-features-medical-marijuana-inc-company-ceo-dr-stuart-titus/
$MJNA Medical Marijuana, Inc. (OTC:MJNA), the first publicly traded cannabis company in the United States, garnered news coverage with a feature story in top national newspaper The Washington Post.
A March 28, 2018 article on The Washington Post’s website entitled “CBD is cannabis that won’t get you high. So why are so many people using it?” takes a deep dive into the story behind the rise in popularity of cannabidiol (CBD) in the United States. The article quotes Medical Marijuana, Inc. CEO Dr. Stuart Titus and recognizes Medical Marijuana, Inc. as a producer of several CBD oils and products that entered the market in 2012.
Medical Marijuana, Inc. was the first company to ever create a global CBD pipeline with its flagship product, Real Scientific Hemp Oil™ (RSHO™), and now has several distribution subsidiaries such as HempMeds®, Kannaway® and Phyto Animal Health. The company also operates in many other countries around the world and was the first to receive historic federal government import approvals for its CBD products in the nations of Brazil, Mexico and Paraguay. The company has since set up distribution subsidiaries in those countries as well.
“We are thrilled to be acknowledged by such a prestigious national publication highlighting Medical Marijuana, Inc. as a leader in the CBD industry,” said Medical Marijuana, Inc. CEO Dr. Titus. “This kind of media coverage helps us communicate the health and wellness benefits of CBD, while shedding light on the company’s accomplishments.”
About Medical Marijuana, Inc.
We are a company of firsts®. Our mission is to be the premier cannabis and hemp industry innovators, leveraging our team of professionals to source, evaluate and purchase value-added companies and products, while allowing them to keep their integrity and entrepreneurial spirit. We strive to create awareness within our industry, develop environmentally-friendly, economically sustainable businesses, while increasing shareholder value. For details on Medical Marijuana, Inc.’s portfolio and investment companies, visit www.medicalmarijuanainc.com.
https://www.medicalmarijuanainc.com/top-u-s-newspaper-washington-post-features-medical-marijuana-inc-company-ceo-dr-stuart-titus/
$MJNA Leading Stock Website The Motley Fool Features Medical Marijuana, Inc. as the Only Potential Publicly-Traded Winner of Hemp Farming Act of 2018
https://www.bizjournals.com/sanjose/prnewswire/press_releases/California/2018/04/03/LA55081
$MJNA Leading Stock Website The Motley Fool Features Medical Marijuana, Inc. as the Only Potential Publicly-Traded Winner of Hemp Farming Act of 2018
https://www.bizjournals.com/sanjose/prnewswire/press_releases/California/2018/04/03/LA55081
$POTN Forecast Indicates CBD Global Market Projected to Experience Continued Significant Growth
https://www.prnewswire.com/news-releases/forecast-indicates-cbd-global-market-projected-to-experience-continued-significant-growth-678632383.html
MJNA Forecast Indicates CBD Global Market Projected to Experience Continued Significant Growth
https://www.prnewswire.com/news-releases/forecast-indicates-cbd-global-market-projected-to-experience-continued-significant-growth-678632383.html
If Trump Legalizes Cannabis on the Federal Level, the Sector Could Boom
https://www.prnewswire.com/news-releases/if-trump-legalizes-cannabis-on-the-federal-level-the-sector-could-boom-686151791.html
If Trump Legalizes Cannabis on the Federal Level, the Sector Could Boom
https://www.prnewswire.com/news-releases/if-trump-legalizes-cannabis-on-the-federal-level-the-sector-could-boom-686151791.html
$MJNA Medical Marijuana, Inc. Subsidiary HempMeds(R) Brasil Hosts Cannabis Symposium for Brazilian Doctors at Offices in San Diego https://www.epicos.com/article/152282/medical-marijuana-inc-subsidiary-hempmedsr-brasil-hold-its-second-doctor-symposium
$MJNA Medical Marijuana, Inc. Subsidiary HempMeds(R) Brasil Hosts Cannabis Symposium for Brazilian Doctors at Offices in San Diego https://www.epicos.com/article/152282/medical-marijuana-inc-subsidiary-hempmedsr-brasil-hold-its-second-doctor-symposium
$MJNA Medical Marijuana, Inc. Subsidiary HempMeds® Garners National Media Coverage on TMZ Entertainment News https://www.medicalmarijuanainc.com/medical-marijuana-inc-subsidiary-hempmeds-garners-national-media-coverage-tmz-entertainment-news/
$MJNA Medical Marijuana, Inc. Subsidiary HempMeds® Garners National Media Coverage on TMZ Entertainment News https://www.medicalmarijuanainc.com/medical-marijuana-inc-subsidiary-hempmeds-garners-national-media-coverage-tmz-entertainment-news/
$MJNA Medical Marijuana (OTCPK:MJNA +2.1%) Q1 revenue growth of more than 190% Y/Y exceeding $10.5M.
Total gross profits for the quarter increased more than 30% to $3.3M.
Wholly-owned subsidiary Kannaway revenues increased more than 325% to $7.5M.
"In Q1 2018, we had the best revenue quarter in the history of our Company," said Medical Marijuana, Inc. CEO Dr. Stuart Titus. "We're excited that, with the help of our investors, spokespeople and customers, we've experienced tremendous growth and the company is positioned well for continued explosive expansion."
https://seekingalpha.com/news/3358981-medical-marijuana-announces-q1-largest-sales-revenue-quarter-company-history
$MJNA Medical Marijuana (OTCPK:MJNA +2.1%) Q1 revenue growth of more than 190% Y/Y exceeding $10.5M.
Total gross profits for the quarter increased more than 30% to $3.3M.
Wholly-owned subsidiary Kannaway revenues increased more than 325% to $7.5M.
"In Q1 2018, we had the best revenue quarter in the history of our Company," said Medical Marijuana, Inc. CEO Dr. Stuart Titus. "We're excited that, with the help of our investors, spokespeople and customers, we've experienced tremendous growth and the company is positioned well for continued explosive expansion."
https://seekingalpha.com/news/3358981-medical-marijuana-announces-q1-largest-sales-revenue-quarter-company-history
$MJNA has 85 employees. Medical Marijuana, Inc., an investment holding company, operates in the medical marijuana and industrial hemp markets. Its products range from patented and proprietary based cannabinoid products to seed and stalk or isolated high value extracts manufactured and formulated for the pharmaceutical, nutraceutical, and cosmeceutical industries. The company licenses its proprietary testing, genetics, labeling and packaging, tracking, production, and standardization methods for the medicinal cannabinoid industry. It engages in the research and development of cannabinoid-based pharmaceuticals; and marketing and distribution of cannabidiol hemp oil-based products. In addition, the company provides management support and services to cooperatives, collectives, health and wellness facilities, and medical clinics; and consulting and securities services to businesses and individuals in the legal cannabis industry. Further, it focuses on the treatment of pain and other medical disorders with the application of chewing gum-based cannabis/cannabinoid medical products. Medical Marijuana, Inc. was formerly known as Hemp Deposit Distribution Corp. and changed its name to Medical Marijuana, Inc. in March, 2011. Enormous Market cap at $328.701 Million. Has total cash of $2.31 Million. The company was incorporated in 2003 and is headquartered in Poway, California. Undervalued Cannabis & Hemp Pipeline: https://www.medicalmarijuanainc.com/
$MJNA has 85 employees. Medical Marijuana, Inc., an investment holding company, operates in the medical marijuana and industrial hemp markets. Its products range from patented and proprietary based cannabinoid products to seed and stalk or isolated high value extracts manufactured and formulated for the pharmaceutical, nutraceutical, and cosmeceutical industries. The company licenses its proprietary testing, genetics, labeling and packaging, tracking, production, and standardization methods for the medicinal cannabinoid industry. It engages in the research and development of cannabinoid-based pharmaceuticals; and marketing and distribution of cannabidiol hemp oil-based products. In addition, the company provides management support and services to cooperatives, collectives, health and wellness facilities, and medical clinics; and consulting and securities services to businesses and individuals in the legal cannabis industry. Further, it focuses on the treatment of pain and other medical disorders with the application of chewing gum-based cannabis/cannabinoid medical products. Medical Marijuana, Inc. was formerly known as Hemp Deposit Distribution Corp. and changed its name to Medical Marijuana, Inc. in March, 2011. Enormous Market cap at $328.701 Million. Has total cash of $2.31 Million. The company was incorporated in 2003 and is headquartered in Poway, California. Undervalued Cannabis & Hemp Pipeline: https://www.medicalmarijuanainc.com/
$KNDI Kandi Technologies to Buy a Texas-Based Vehicle Distributor for $10 Million
"The acquisition is an entry point to gain a compelling opportunity for business integration and market expansion in America which will provide Kandi a solid foundation for the future strategic business development," said Xiaoming Hu, Kandi's chairman and CEO.
Sportsman Country was founded as a joint venture between Massimo Motor and Bennche, two off-road vehicle manufacturers also based in Garland, in 2017. Massimo founder, David Shan, serves as chairman, while Bennche founder, Johnny Tai, serves as president and CEO.
Sportsman Country sells vehicle products and parts under the Massimo, Bennche, and Linhai brands. The company has approximately 20 employees and generated around $1 million in pretax profit in 2017.
$KNDI Kandi Technologies to Buy a Texas-Based Vehicle Distributor for $10 Million
"The acquisition is an entry point to gain a compelling opportunity for business integration and market expansion in America which will provide Kandi a solid foundation for the future strategic business development," said Xiaoming Hu, Kandi's chairman and CEO.
Sportsman Country was founded as a joint venture between Massimo Motor and Bennche, two off-road vehicle manufacturers also based in Garland, in 2017. Massimo founder, David Shan, serves as chairman, while Bennche founder, Johnny Tai, serves as president and CEO.
Sportsman Country sells vehicle products and parts under the Massimo, Bennche, and Linhai brands. The company has approximately 20 employees and generated around $1 million in pretax profit in 2017.
$KNDI Kandi Pure Electric Vehicle Product Pursuing Expansion to the American Market http://markets.businessinsider.com/news/stocks/kandi-pure-electric-vehicle-product-pursuing-expansion-to-the-american-market-1026870080
$KNDI Kandi Pure Electric Vehicle Product Pursuing Expansion to the American Market http://markets.businessinsider.com/news/stocks/kandi-pure-electric-vehicle-product-pursuing-expansion-to-the-american-market-1026870080
$INSY Epinephrine Nasal Spray in Development for Treatment of Anaphylaxis Shows Promise as Potential Alternative to Intramuscular Injection https://www.morningstar.com/news/globe-news-wire/GNW_7303654/epinephrine-nasal-spray-in-development-for-treatment-of-anaphylaxis-shows-promise-as-potential-alternative-to-intramuscular-injection.html
$INSY Epinephrine Nasal Spray in Development for Treatment of Anaphylaxis Shows Promise as Potential Alternative to Intramuscular Injection https://www.morningstar.com/news/globe-news-wire/GNW_7303654/epinephrine-nasal-spray-in-development-for-treatment-of-anaphylaxis-shows-promise-as-potential-alternative-to-intramuscular-injection.html